InvestorsHub Logo
Followers 307
Posts 11030
Boards Moderated 1
Alias Born 03/05/2009

Re: rickyricks post# 3133

Saturday, 05/27/2017 9:24:50 PM

Saturday, May 27, 2017 9:24:50 PM

Post# of 3839
Right now GALT is in the drivers seat for NASH therapies.

If they meet their end points with the Phase 2 trial results in December they have a real possibility of getting GR-MD-02 fast tracked to market.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News